Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
49 Results for "
human calcitonin
" in MedChemExpress (MCE) Product Catalog:
Products (49)
49 Results for "human calcitonin" in MCE Product Catalog:
47
47 Publications Verification
Synonyms: BIBN-4096; BIBN 4096BS
Target:
Research Areas:
Olcegepant (BIBN-4096) is a potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and Ki of 14.4 pM for human CGRP .
47
47 Publications Verification
Synonyms: BIBN-4096 hydrochloride; BIBN4096BS hydrochloride
Target:
Research Areas:
Olcegepant hydrochloride (BIBN-4096 hydrochloride) is a potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and with a Ki of 14.4 pM for human CGRP .
6
6 Cited Publications
Cat. No.: HY-P1071
CAS No.: 90954-53-3
Synonyms: calcitonin gene-related peptide
Target:
Research Areas:
6
Target:
Research Areas:
4
Target:
Research Areas:
2
2 Cited Publications
Cat. No.: HY-P1548
CAS No.: 101462-82-2
Synonyms: human β-CGRP; CGRP-II (human)
Target:
Research Areas:
2
Target:
Research Areas:
Telcagepant (MK-0974) is an orally active calcitonin gene-related peptide (CGRP) receptor antagonist with Kis of 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively.
2
Target:
Research Areas:
2
Target:
Research Areas:
1
Target:
Research Areas:
1
1 Cited Publications
Synonyms: Zavegepant; BHV-3500
Target:
Research Areas:
Vazegepant (Zavegepant; BHV-3500) is an orally active calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki of 23 pM for human CGRP receptor and an EC50 of 880 pM for reversing CGRP-induced vasodilation in human intracranial arteries. Vazegepant can block CGRP-mediated vasodilation in the trigeminal vascular system and inhibit neuronal circuit sensitization. Vazegepant can be used in migraine-related research .
1
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P1072
CAS No.: 87403-73-4
Target:
Research Areas:
1
1 Cited Publications
Synonyms: Zavegepant hydrochloride; BHV-3500 hydrochloride
Target:
Research Areas:
Vazegepant (Zavegepant hydrochloride; BHV-3500 hydrochloride) hydrochloride is an orally active calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki of 23 pM for human CGRP receptor and an EC50 of 880 pM for reversing CGRP-induced vasodilation in human intracranial arteries. Vazegepant hydrochloride can block CGRP-mediated vasodilation in the trigeminal vascular system and inhibit neuronal circuit sensitization. Vazegepant hydrochloride can be used in migraine-related research .
Cat. No.: HY-P10798
CAS No.: 2883634-40-8
Synonyms: LY-3841136
Target:
Research Areas:
Cat. No.: HY-P2273
CAS No.: 21215-62-3
Target:
Research Areas:
Synonyms: MK-1602
Target:
Research Areas:
Ubrogepant (MK-1602) is an orally active and selective antagonist of calcitonin gene-related peptide receptor (CGRP). Ubrogepant has high affinity for CGRP receptors in human and rhesus monkeys, and can effectively block the cAMP response stimulated by α-CGRP. Ubrogepant can be used in the study of acute migraine .
Cat. No.: HY-P11274A
Synonyms: Amycretin sodium; NN 9487 sodium
Target:
Research Areas:
Cat. No.: HY-P99017
CAS No.: 1644539-04-7
Synonyms: ALD-403
Target:
Research Areas:
Cat. No.: HY-P4093
CAS No.: 209323-98-8
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
